Outperform Recommendation Issued On ABVX By Citigroup

June 02, 2026 06:15:03 am

Source: KlickAnalytics

2026-06-02 06:15:03 ET

Citigroup analyst issues OUTPERFORM recommendation for ABVX on June 2, 2026 09:41AM ET.

The previous analyst recommendation was Outperform.

ABVX was trading at $129.69 at issue of the analyst recommendation.

The overall analyst consensus : BUY.

Current analyst recommendations are : 9 - Buy recommendations .

Latest 10 recommendations

Full story available on KlickAnalytics.com

Abivax SA

17.52% G/L:

$82.85 Last:

4,169,906 Volume:

$81.26 Open:

June 03, 2026 08:53:00 pm

June 03, 2026 05:35:00 pm

June 03, 2026 03:15:03 pm

June 02, 2026 09:20:00 pm

Market Cap $9,359,969,582

Float 53,161,297

Insiders Ownership N/A

Institutions 64

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Website www.abivax.com

Country FR

City Paris